123 related articles for article (PubMed ID: 33325919)
1. Nuclear delivery of dual anti-cancer drugs by molecular self-assembly.
Wu J; Ding W; Han G; You W; Gao W; Shen H; Tang J; Tang Q; Wang X
Biomater Sci; 2021 Jan; 9(1):116-123. PubMed ID: 33325919
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cellular uptake and nuclear accumulation of drug-peptide nanomedicines prepared by enzyme-instructed self-assembly.
Liang C; Yan X; Zhang R; Xu T; Zheng D; Tan Z; Chen Y; Gao Z; Wang L; Li X; Yang Z
J Control Release; 2020 Jan; 317():109-117. PubMed ID: 31778740
[TBL] [Abstract][Full Text] [Related]
3. Supramolecular nanofibers increase the efficacy of 10-hydroxycamptothecin by enhancing nuclear accumulation and depleting cellular ATP.
Guo Q; Liu Y; Wang Z; Zhang J; Mu G; Wang W; Liu J
Acta Biomater; 2021 Mar; 122():343-353. PubMed ID: 33444804
[TBL] [Abstract][Full Text] [Related]
4. Nuclear delivery of dual anticancer drug-based nanomedicine constructed by cisplatinum-induced peptide self-assembly.
Xu T; Liang C; Zheng D; Yan X; Chen Y; Chen Y; Li X; Shi Y; Wang L; Yang Z
Nanoscale; 2020 Jul; 12(28):15275-15282. PubMed ID: 32644059
[TBL] [Abstract][Full Text] [Related]
5. Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy.
Niu F; Yan J; Ma B; Li S; Shao Y; He P; Zhang W; He W; Ma PX; Lu W
Biomaterials; 2018 Jun; 167():132-142. PubMed ID: 29571049
[TBL] [Abstract][Full Text] [Related]
6. Supramolecular "Trojan Horse" for Nuclear Delivery of Dual Anticancer Drugs.
Cai Y; Shen H; Zhan J; Lin M; Dai L; Ren C; Shi Y; Liu J; Gao J; Yang Z
J Am Chem Soc; 2017 Mar; 139(8):2876-2879. PubMed ID: 28191948
[TBL] [Abstract][Full Text] [Related]
7. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
8. Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions.
Li C; Pazgier M; Li C; Yuan W; Liu M; Wei G; Lu WY; Lu W
J Mol Biol; 2010 Apr; 398(2):200-13. PubMed ID: 20226197
[TBL] [Abstract][Full Text] [Related]
9. A tetrameric protein scaffold as a nano-carrier of antitumor peptides for cancer therapy.
Ma B; Niu F; Qu X; He W; Feng C; Wang S; Ouyang Z; Yan J; Wen Y; Xu D; Shao Y; Ma PX; Lu W
Biomaterials; 2019 Jun; 204():1-12. PubMed ID: 30861422
[TBL] [Abstract][Full Text] [Related]
10. A lanthanide-peptide-derived bacterium-like nanotheranostic with high tumor-targeting, -imaging and -killing properties.
He W; Yan J; Wang L; Lei B; Hou P; Lu W; Ma PX
Biomaterials; 2019 Jun; 206():13-24. PubMed ID: 30921731
[TBL] [Abstract][Full Text] [Related]
11. Self-Assembled Peptide-Lanthanide Nanoclusters for Safe Tumor Therapy: Overcoming and Utilizing Biological Barriers to Peptide Drug Delivery.
Yan J; He W; Yan S; Niu F; Liu T; Ma B; Shao Y; Yan Y; Yang G; Lu W; Du Y; Lei B; Ma PX
ACS Nano; 2018 Feb; 12(2):2017-2026. PubMed ID: 29376322
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment.
Mao C; Li F; Zhao Y; Debinski W; Ming X
Theranostics; 2018; 8(22):6274-6290. PubMed ID: 30613297
[TBL] [Abstract][Full Text] [Related]
13. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.
Soares J; Espadinha M; Raimundo L; Ramos H; Gomes AS; Gomes S; Loureiro JB; Inga A; Reis F; Gomes C; Santos MMM; Saraiva L
Mol Oncol; 2017 Jun; 11(6):612-627. PubMed ID: 28296148
[TBL] [Abstract][Full Text] [Related]
14. A peptide-drug hydrogel to enhance the anti-cancer activity of chlorambucil.
Guo Q; Liu Y; Mu G; Yang L; Wang W; Liu J; Liu J
Biomater Sci; 2020 Oct; 8(20):5638-5646. PubMed ID: 32945821
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
16. Efficient reactivation of p53 in cancer cells by a dual MdmX/Mdm2 inhibitor.
Qin L; Yang F; Zhou C; Chen Y; Zhang H; Su Z
J Am Chem Soc; 2014 Dec; 136(52):18023-33. PubMed ID: 25453499
[TBL] [Abstract][Full Text] [Related]
17. A Hierarchical Peptide-Lanthanide Framework To Accurately Redress Intracellular Carcinogenic Protein-Protein Interaction.
Yan J; Yan S; Hou P; Lu W; Ma PX; He W; Lei B
Nano Lett; 2019 Nov; 19(11):7918-7926. PubMed ID: 31645103
[TBL] [Abstract][Full Text] [Related]
18. d-Amino acid mutation of PMI as potent dual peptide inhibitors of p53-MDM2/MDMX interactions.
Li X; Liu C; Chen S; Hu H; Su J; Zou Y
Bioorg Med Chem Lett; 2017 Oct; 27(20):4678-4681. PubMed ID: 28916339
[TBL] [Abstract][Full Text] [Related]
19. Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action.
Voruganti S; Qin JJ; Sarkar S; Nag S; Walbi IA; Wang S; Zhao Y; Wang W; Zhang R
Oncotarget; 2015 Aug; 6(25):21379-94. PubMed ID: 26041888
[TBL] [Abstract][Full Text] [Related]
20. Pro-Nifuroxazide Self-Assembly Leads to Triggerable Nanomedicine for Anti-cancer Therapy.
Misra SK; Wu Z; Ostadhossein F; Ye M; Boateng K; Schulten K; Tajkhorshid E; Pan D
ACS Appl Mater Interfaces; 2019 May; 11(20):18074-18089. PubMed ID: 31013055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
